Purpose We investigated prospectively the relationship between dietary intakes of methionine and B vitamins associated with one-carbon metabolism and breast cancer risk, including modification by age, hormone receptor status and alcohol consumption. Interactions between different B vitamins and methionine were also examined. Methods During follow-up of 20,756 women from the Melbourne Collaborative Cohort Study for an average of 16 years, we ascertained 936 incident breast cancers. Dietary intakes were estimated using a 121-item food frequency questionnaire. Hazard ratios (HR) and 95 % confidence intervals were estimated using Cox regression. Results We found weak evidence for an inverse association between breast cancer risk and riboflavin intake (fourth versus first quartile, HR Q4 vs. Q1 = 0.84 (0.69, 1.01); p linear trend = 0.05) and a positive association for vitamin B12 (HR Q4 vs. Q1 = 1.21 (1.00, 1.46); p linear trend = 0.06). We did not find any significant interactions between alcohol consumption and any of the B vitamins or methionine intake (all p interaction [ 0.17) or between methionine or folate intake and any other B vitamins (all p interaction [ 0.07). No association varied by tumor hormone receptor status (all p homogeneity [ 0.14). Conclusions We found weak evidence of an inverse association between breast cancer risk and riboflavin intake and a positive association with vitamin B12.
Introduction
One-carbon metabolism comprises a complex network of biochemical pathways, involving interactions between several B vitamins, homocysteine and methionine. Folate and methionine are major sources of dietary methyl groups. Riboflavin, vitamin B6 and vitamin B12 are important cofactors in the one-carbon metabolism and might modulate the bioavailability of methyl groups. Disruption of onecarbon metabolism can interfere with DNA replication, DNA repair and regulation of gene expression through methylation, each of which could promote carcinogenesis [1] . Thus, dietary intake of B vitamins and methionine might play an important role in the development and progression of cancer.
Studies investigating associations between B vitamins and breast cancer risk have mainly focused on folate, vitamin B6 and B12. Two recent meta-analyses found no evidence from prospective studies for an association with dietary folate intake, whereas an inverse association was found for case-control studies [2, 3] . However, heterogeneity among studies within each type of study design was noted [2] , as was publication bias among case-control studies [3] . Most studies have generally reported null findings for overall breast cancer risk and vitamin B6 [4] [5] [6] [7] [8] [9] [10] [11] [12] , vitamin B12 [4, [7] [8] [9] [10] [11] 13] , riboflavin [8-10, 14, 15] and methionine [4, 6, 10, 13, 15] .
Associations between B vitamin and methionine intake and breast cancer risk might be modified by other factors. It has been hypothesized that low folate intake might be associated with ER-breast tumors through its influence on methylation of the ER receptor, which could affect silencing of these genes [16] , and some studies support this association [9, 17] . Others have investigated modification by hormone receptor status with inconsistent findings [6, 18, 19] . High alcohol consumption is associated with increased breast cancer risk [20] , and alcohol, a known folate antagonist, can impair folate absorption and metabolism [21] . Adequate folate intake might attenuate the increased risk of breast cancer associated with alcohol consumption [2] . Other nutrients involved in the one-carbon metabolism might modify the association between folate and breast cancer, given the complex interactions involved, but findings have been inconsistent [2] .
We investigated prospectively the relationship between dietary intakes of methionine and B vitamins associated with one-carbon metabolism and breast cancer risk, including modification by age, hormone receptor status and alcohol consumption. Interactions between different B vitamins and methionine were also examined.
Materials and methods

The cohort
The Melbourne Collaborative Cohort Study (MCCS) is a prospective cohort study of 41,514 people (24,469 women) aged 27-80 at baseline [22] . The study protocol was approved by The Cancer Council Victoria's Human Research Ethics Committee. Follow-up has been conducted by record linkage to electoral rolls, electronic phone books, the Victorian Cancer Registry (VCR) and Victorian death records until 30 June 2010.
Subjects
We excluded women who had a diagnosis of breast cancer before study entry (n = 448) were missing data for any of the nutrients of interest (n = 11) and those who reported extreme values (top or bottom percentile) of total energy intake (n = 484). Women who reported a diagnosis of angina, heart attack or diabetes at baseline (n = 1,402) were also excluded as they might have changed their diet due to their diagnosis. Ex-drinkers were also excluded as it was unknown how long these women had abstained from alcohol (n = 691). Those with missing values for any of the confounders (n = 676) and one woman who reported an unconfirmed cancer diagnosis 2 years after leaving Australia were also excluded from the analyses. Altogether, data from 20,756 women including 936 incident cases were available for the analysis of total breast cancer. ER and PR status were unknown for 71 and 91 women, respectively, leaving 869 cases available for the ER/PR status analyses. There were no appreciable differences in baseline characteristics between women who had ER and PR status known and those who did not (all p [ 0.05). 
Identification of incident breast cancer cases
ER and PR status
The medical records of women with breast cancer were reviewed, and their cancers classified according to ER and PR status as recorded in histopathology reports held at the VCR. ER? and PR? tumors were identified as those with C1 % staining or weak, moderate or strong intensity, and ER-and PR-tumors were identified as those with no staining. We repeated measurements of ER and PR status for a subset of cases with archival tissue available (77 % of all cases in the sample). Immunohistochemistry techniques used to determine ER and PR status have been described in detail elsewhere [23] . The agreements between ER and PR status assessed by immunohistochemistry and the values held by the VCR were 90 and 73 %, respectively (for ER, j = 0.54, p \ 0.0001; for PR, j = 0.36, p \ 0.0001). Given the good agreement between the ER and PR data, when archival tumor tissue was unavailable, ER and PR status was assigned according to the histopathology reports held at the VCR. For the hormonal receptor analyses, we had the following subtype combinations: 690 cases with ER? or PR? (ER?/PR?) and 179 cases with ER-and PR-(ER-and PR-).
Nutrient measures
Participants completed a 121-item food frequency questionnaire (FFQ) specifically developed for the MCCS [24] and answered additional questions about alcohol intake. Sex-specific average portion sizes were assigned to each food item, and daily frequencies of some fruits were seasonally adjusted. Nutrient composition data for the B vitamins and methionine were derived from the Australian NUTTAB 2006 database [25] . Mean daily intakes for the 5 nutrients [riboflavin (vitamin B2), vitamin B6, folate (vitamin B9), vitamin B12 and methionine] were obtained by multiplying the daily frequency of each food item by the nutrient composition for an average sex-specific portion size. Folate intake only included that occurring naturally in foods. Although the FFQ has been validated for fatty acids [26] and carotenoids [27] , it has not been validated specifically for B vitamins.
Baseline data collection A structured interview was used to obtain information on reproductive history, hormone replacement therapy (HRT), oral contraceptive (OC) use, ethnicity, highest level of education, alcohol consumption, smoking status and physical activity (see Ref. [28] for further details). Height and weight were measured and BMI was calculated from these.
Statistical analysis
Follow-up began at study entry and continued until date of diagnosis of breast cancer or an unknown primary cancer, an unconfirmed breast cancer diagnosis, death, last known to be in Australia, last known to be in Victoria if after 2004 or 30 June 2010, whichever came first.
Intakes of energy and each nutrient were log transformed, and then, nutrient intakes were adjusted for energy using the residuals method [29] . Quartile cut points (Q) for each energy-adjusted nutrient were obtained from the whole sample, the lowest quartile (Q1) being the referent category. To estimate linear trends on a log hazard scale, each nutrient variable was fitted as a pseudocontinuous covariate (using the median Q values). To investigate departures from linearity in the relationship between nutrient intake and breast cancer risk, we included a quadratic pseudocontinuous term for each nutrient in these models and assessed the significance of this term using the Wald test.
Cox regression models were fitted, with age as the time axis [30] , to estimate hazard ratios (HRs) and 95 % confidence intervals, separately for each nutrient measure and for alcohol consumption. To test for heterogeneity in the HRs by attained age at follow-up (B55 vs. [55 years, where 55 years was the age at which 95 % of women in our sample had reached the menopause), we split the attained age during follow-up into the two specified age groups and fitted Cox models with an interaction term between each nutrient and the age groups. To test for heterogeneity in the HRs by hormone receptor status (ER?/PR? vs. ER-and PR-), we fitted Cox regression models for competing risk using a data duplication method [31] .
All analyses were adjusted for ethnicity (Australian/ New Zealand, United Kingdom, Greek, Italian), menopausal status (pre, post), age at menarche (\12, 12, 13, C14 years), parity and lactation (nulliparous, parous and never lactated, parous and lactated), OC use (never, ever), HRT use (never, ex-user, current user), physical activity score (0, [0 to \4, 4 to \6, C6), alcohol consumption (lifetime abstainer, low 1-19 g/day, moderate 20-39 g/ day, high intake C40 g/day), smoking status (never, current, former), education (primary school, some high school, completed high school, completed degree/diploma) and BMI. Models for alcohol consumption were also adjusted for daily energy from food. Interactions between hormone receptor subtype and each confounder were included in our competing risk models.
To examine the interaction of each B vitamin with methionine and the interaction of each nutrient with folate, nutrient intakes were dichotomized at the medians. Separate Cox regression models were fitted for ER?/PR? and ER-and PR-breast cancer. Due to few women in the high alcohol consumption category, each nutrient was treated as a continuous variable and the four alcohol consumption categories were retained in our models, to investigate the interaction of each nutrient with alcohol.
We conducted sensitivity analyses by repeating our analyses including only women of Australian, New Zealand or United Kingdom descent, using ER and PR measures obtained from immunohistochemistry only or the VCR only, excluding women who reported consuming multivitamins at baseline, excluding women with cancer at any site prior to baseline and excluding the first 2 years of follow-up to eliminate the possibility that the observed relationships were influenced by preexisting disease. Mandatory folate fortification of bread flour was introduced in Australia during 2009 [32] . To determine whether folate fortification influenced our findings, we repeated our analyses using the end of follow-up as 31 December 2008, to investigate associations in the pre-fortification period.
Statistical analyses were performed using Stata/SE 12.1 (Stata Corporation, College Station, TX, USA). p \ 0.05 (two-sided) was considered statistically significant. Tests based on Schoenfeld residuals showed no evidence of violation of the proportional hazards assumption. Baseline characteristics and mean daily energy-adjusted nutrient intakes for the study sample are shown in Table 1 .
Results
Of
Spearman correlation coefficients between energy-adjusted intakes of riboflavin and folate (q = 0.37), vitamin B12 and vitamin B6 (q = 0.50) and vitamin B12 and methionine (q = 0.56) were moderate, but weak between the other B vitamins and methionine (all q \ 0.17; data not shown). We did not observe any statistically significant interactions between alcohol consumption and intake of B vitamins or methionine for overall breast cancer risk (all p interaction [ 0.17). We did not have enough cases in the high alcohol consumption group to assess alcohol-nutrient interactions by hormonal receptor status.
We did not observe any significant interactions between methionine or folate and the other B vitamins for overall Additional analyses excluding the first 2 years of follow-up, including only women of Australian, New Zealand or United Kingdom descent, using ER and PR measures obtained from immunohistochemistry only or the VCR only, excluding women who reported consuming multivitamins at baseline, excluding women with pre-baseline cancer at any site and including only the pre-folate fortification period (follow-up to the end of 2008) did not materially change the HR estimates.
Discussion
Overall, we found suggestive evidence of a weak inverse association between riboflavin intake and breast cancer risk, and a weak positive association for vitamin B12 intake. We found no linear associations with alcohol consumption, although there was weak evidence that higher intakes were associated with higher risk, particularly for ER?/PR? subtype. We did not observe any significant interactions between alcohol consumption, folate, methionine and any of the other nutrients for overall breast cancer risk. Nonetheless, there was some evidence to suggest that higher methionine intakes might protect against breast Our study strengths include virtually complete follow-up as the identification of incident breast cancer cases was performed by record linkage to the Australian population-based cancer registries that have complete coverage of the cohort participants. Although the interstate linkage is complete only up to the end of 2004, only 3 cases were diagnosed interstate between 1990 and 2004; thus, it is unlikely that we have missed many interstate cases. Only 0.2 % of women left Australia during follow-up, so we would not expect to have missed many cases diagnosed overseas. Analyses excluding the first 2 years of follow-up gave similar associations with those reported; thus, it is unlikely that our findings were influenced by preexisting disease. Further analyses restricted to women of Australian, New Zealand or United Kingdom descent or women who did not report any pre-baseline cancer at any site did not substantially affect our findings, nor did restricting our hormone receptor status analyses to using measures obtained from immunohistochemistry reports only or the VCR only.
Our study's limitations include the fact that information on diet and potential confounding variables was only collected at baseline and might not be relevant to the full time period. We could not account for any change in dietary habits over follow-up, although older people tend to have stable diets [33] . Further, inter-correlations between B vitamins and methionine [34] make it difficult to estimate the effect of a single nutrient. Our FFQ has not been validated specifically for B vitamins, only for fatty acids [26] and carotenoids [27] . However, a similar FFQ which was derived from the one used in the current study has been previously validated for some B vitamins [35] . For some subgroups, particularly for interaction analyses and in our highest alcohol consumption category, the small number of cases led to low precision. Given the number of comparisons performed, some associations might be due to chance alone. Voluntary folic acid fortification of foods has been progressively introduced in Australia, and fortification of bread flour has been mandatory since 2009 [32] Although we were unable to account for this, there were no substantial differences in associations when we restricted our analyses to the pre-fortification period (using the end of follow-up as the end of 2008). Some misclassification of nutrient intake is inevitable since we only assessed dietary intake and did not have data on supplemental B vitamin intake. However, only 19 % of women in our sample used multivitamins, so it is unlikely that this lack of information would have substantially affected our estimates. Furthermore, analyses restricted to women who did not consume multivitamins at baseline showed similar associations with those for all women in our study. Intakes of B vitamins are estimated from FFQs with considerable error; a fact supported by the weak correlations between dietary and serum levels of B vitamins [6, 36] , although metabolic effects may also contribute to variations in circulating levels. Misclassification of dietary intakes will attenuate any estimate of association between diet and cancer and could, thus, contribute to differences in the results between studies using dietary intakes or biomarkers.
Generally, no linear associations have been reported for dietary intakes of riboflavin [9, 10, 15] , although a weak inverse association was reported by the Long Island Breast Cancer Study Project, a population-based case-control study, but only among non-supplemental users [14] . Consistent with our findings, nonsignificant reduced risks were reported for higher intakes of riboflavin in some studies [9, 10, 14] . We did not observe any associations by hormone receptor subtype, consistent with others [8, 10] .
Some studies have reported no linear associations for dietary intakes of B6 for overall breast cancer risk [4] [5] [6] [8] [9] [10] [11] or by ER or PR subtype [4, 8, 10] , consistent with our findings. A suggestive J-shaped association with overall breast cancer was reported from a case-control study nested within the Women's Health Study for total B6 intake, but not for B6 from food only [6] and a Japanese hospital-based case-control study reported a possible U-shaped association with B6 intake [8] . These studies are consistent with the suggestive J-shaped relationship we observed for total breast cancer risk and the U-shaped relationship for ER-and PRsubtype for dietary B6 intake.
Most studies reported no association for vitamin B12 intake, for overall breast cancer risk [4, [7] [8] [9] [10] [11] 13] or by hormonal receptor subtype [4, 8, 10] . The weak positive association we observed for vitamin B12 intake for total breast cancer was consistent with findings from a casecontrol study nested within the Women's Health Study for total B12 intake [6] . They reported a HR of 1.44 [1.02, 2.04] for the highest versus lowest quintile, but no association was observed for B12 intake from food only [6] .
Evidence from experimental studies suggests that folate deficiency might promote initial stages of carcinogenesis, whereas excess folic acid might stimulate existing neoplasms [37] [38] [39] ; however, we did not find an overall association between breast cancer risk and folate intake. Two recent meta-analyses reported no association between breast cancer risk and folate intake in prospective studies, consistent with our findings, but reported an inverse association in casecontrol studies [2, 3] . However, Larsson et al. [2] identified heterogeneity between studies of each type of study design, and Lewis et al. [3] noted that the association between breast cancer risk and folate intake observed in the case-control studies might be due to a combination of chance, bias, measurement error and/or confounding. We did not find any associations for ER?/PR? or ER-and PR-subtypes consistent with others [8, 18] . Inconsistent associations have been reported by others for ER and PR status and various combinations of these receptors [6, 9, 10, 17, 19] .
Several studies reported no associations for methionine intake and overall breast cancer risk [4, 10, 13, 15] or by hormone receptor status [10] , consistent with our findings, but in contrast to an inverse association reported by the Cancer Prevention Study II Nutrition Cohort [11] .
Epidemiological studies have consistently reported a modest positive association between alcohol consumption and breast cancer risk, particularly for hormone receptor positive tumors [20] , which is consistent with the weak elevated risks we observed in our study for overall breast cancer and ER?/PR? tumors for heavier drinkers. Alcohol is a known folate antagonist that can impair folate absorption and metabolism [21] . Although there is evidence that the association between breast cancer risk and alcohol consumption might be modified by intakes of folate [20] , including in an earlier study using MCCS data with a shorter follow-up period (and restricted to Anglo-Australian women) [40] , we did not find a significant interaction between alcohol and folate, consistent with others [4, 9, 11, 15, 18, [41] [42] [43] . Two studies reported a stronger protective effect for ER-with higher intakes of folate for higher alcohol consumers [17, 44] . We did not have enough cases to investigate folatealcohol interactions by hormonal receptor status. Consistent with others, we found no significant interactions between alcohol and riboflavin [8, 15] , vitamin B6 [4, 8, 11] , vitamin B12 [4, 8, 11] or methionine [4, 11, 15] .
In one folate-metabolism pathway, the enzyme, 5,10-methylenetetrahydrofolate reductase (MTHFR) catalyzes the irreversible conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, the primary circulating form of folate which is used for the remethylation of homocysteine to methionine. MTHFR redirects the pool of folate from DNA synthesis/repair to methylation. Thus, MTHFR activity and availability of folate might affect DNA methylation and DNA synthesis, and there is some evidence that MTHFR genotypes might modify the association between dietary intake of B vitamins and breast cancer risk [45] [46] [47] . We observed an increased risk of breast cancer associated with high folate intakes for women with low methionine intakes, which is in contrast to what we might expect; however, other factors such as MTHFR affect circulating folate and methionine, and we were unable account for these. Others have generally reported no strong evidence of a folate-methionine interaction and breast cancer [4, [9] [10] [11] 15] . Consistent with others, we found no strong evidence that folate modified the associations between breast cancer risk and riboflavin [9, 10, 15, 41] , vitamin B6 [4, [9] [10] [11] or vitamin B12 [4, [9] [10] [11] .
Our findings suggest a weak inverse association between breast cancer risk and riboflavin intake and a weak positive association for vitamin B12. We found some evidence that high methionine intake might be protective of breast cancer in women with high folate intakes.
